Overview: HSB 25, "A bill for an act relating to controlled substances, including certain controlled substances schedules and precursor substances reporting requirements, making penalties applicable, and including effective date provisions."
Status: Committee report approving bill, renumbered as HF 182.
Introduced: January 15, 2025
Purpose and Intent: The bill aims to update the state's controlled substances laws, including revising the schedules of certain controlled substances and modifying reporting requirements for precursor substances.
Key Provisions:
- Adds several new substances to the state's controlled substances schedules, including certain synthetic opioids and stimulants.
- Requires pharmacies and other entities to report the sale of certain precursor substances used in the manufacture of controlled substances.
- Establishes penalties for the possession, manufacture, and distribution of the newly scheduled controlled substances.
Affected Parties and Impacts:
- Individuals who manufacture, distribute, or possess the newly scheduled controlled substances, who will be subject to increased criminal penalties.
- Pharmacies and other businesses that sell precursor substances, which will be required to comply with new reporting requirements.
- Law enforcement and the criminal justice system, which will be responsible for enforcing the updated controlled substances laws.
Procedural and Timeline Considerations:
The bill has been approved by a committee and renumbered as HF 182. It will now proceed through the legislative process, with potential further consideration and amendments before a final vote.
